New research reveals that people who discontinue popular weight-loss injections like semaglutide or tirzepatide may regain lost weight far faster than those who halt conventional lifestyle regimens.
Findings released in a leading medical journal demonstrates that while overweight people frequently drop about a fifth of their body weight while on the medication, the mass returns at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals purchasing such drugs must be aware of the potential of rapid weight regain when the medication concludes," cautioned researcher Dr. Susan Jebb.
Such speed of regain suggests a reversion to starting mass in about one and a half years.
Analyzing Approaches
The research, which reviewed dozens of trials involving thousands of participants, compared the outcomes of the injectable medications with older methods.
Scientists note that individuals who shed pounds through dieting usually have a more gradual creep back—around 0.1 kg a month—once they finish.
Explaining the Quick Regain
Nutrition scientists suggest the way of the drugs accounts for the heightened weight return.
GLP-1 drugs copy a body's own chemical called GLP-1, which controls hunger.
"Long-term administration of GLP-1 levels far above than the body's typical production may cause the system to generate a reduced amount of its own natural hormone, and could lessen sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement results in appetite is no longer kept in check, making overeating a significant risk."
A Lifelong Issue?
Health authorities suggest the injections for people with weight-linked health risks, alongside prescribed diet and exercise modifications.
A number of clinicians argue that, due to the significant potential of weight regain, the treatment might need to be ongoing.
This perspective is reinforced by pharmaceutical companies, who note that the results "highlight the long-term nature of obesity," comparing it to managing conditions like high blood pressure.
User Accounts
People who have stopped the jabs explain a intense resurgence of cravings.
"It was like a trigger flipping and you become ravenous," recalled an individual.
The struggle is compounded if patients have not adopted sustainable dietary or behavioural changes during treatment.
Widespread Interest
Figures suggest that millions of people in the UK have used these injections in the last 12 months, with desire continuing to grow.
- Use is greater among women compared to men.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion obtain the drugs through private healthcare rather than public health services.
Finally, experts stress that while the jabs are powerful tools for weight loss, they are not a permanent fix and maintained weight loss relies on integrated lifestyle support.
